Invention Grant
- Patent Title: IL17 and IFN-gamma inhibition for the treatment of autoimmune inflammation
-
Application No.: US13360050Application Date: 2012-01-27
-
Publication No.: US08592456B2Publication Date: 2013-11-26
- Inventor: Johann Leban , Stefan Tasler , Roland Baumgartner , Wael Saeb , Carine Chevrier
- Applicant: Johann Leban , Stefan Tasler , Roland Baumgartner , Wael Saeb , Carine Chevrier
- Applicant Address: DE Planegg-Martinsried
- Assignee: 4SC Discovery GmbH
- Current Assignee: 4SC Discovery GmbH
- Current Assignee Address: DE Planegg-Martinsried
- Agency: Millen, White, Zelano & Branigan, P.C.
- Priority: EP11152515 20110128
- Main IPC: A61K31/454
- IPC: A61K31/454 ; A61K31/444 ; A61K31/4439 ; A61K31/422 ; C07D401/14 ; C07D405/14 ; C07D405/04
Abstract:
The present invention relates to compounds of the general formula (I), and the pharmaceutically acceptable salt or solvate thereof, as anti-inflammatory and immunomodulatory agents.
Public/Granted literature
- US20120196861A1 IL17 AND IFN-GAMMA INHIBITION FOR THE TREATMENT OF AUTOIMMUNE INFLAMMATION Public/Granted day:2012-08-02
Information query
IPC分类:
